Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • Log out
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiology, Biomarkers & Prevention
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Short Communication

Sedentary Behavior and Prostate Cancer Risk in the NIH–AARP Diet and Health Study

Brigid M. Lynch, Christine M. Friedenreich, Karen A. Kopciuk, Albert R. Hollenbeck, Steven C. Moore and Charles E. Matthews
Brigid M. Lynch
1Physical Activity Laboratory, Baker IDI Heart and Diabetes Institute; 2Melbourne School of Population and Global Health, Faculty of Medicine, Dentistry, and Health Sciences, The University of Melbourne, Melbourne, Australia; 3Department of Population Health Research, Alberta Health Services–CancerControl; Departments of 4Oncology, 5Community Health Sciences, and 6Mathematics and Statistics, University of Calgary, Calgary, Canada; 7AARP, Washington, DC; and 8Nutritional Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland
1Physical Activity Laboratory, Baker IDI Heart and Diabetes Institute; 2Melbourne School of Population and Global Health, Faculty of Medicine, Dentistry, and Health Sciences, The University of Melbourne, Melbourne, Australia; 3Department of Population Health Research, Alberta Health Services–CancerControl; Departments of 4Oncology, 5Community Health Sciences, and 6Mathematics and Statistics, University of Calgary, Calgary, Canada; 7AARP, Washington, DC; and 8Nutritional Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christine M. Friedenreich
1Physical Activity Laboratory, Baker IDI Heart and Diabetes Institute; 2Melbourne School of Population and Global Health, Faculty of Medicine, Dentistry, and Health Sciences, The University of Melbourne, Melbourne, Australia; 3Department of Population Health Research, Alberta Health Services–CancerControl; Departments of 4Oncology, 5Community Health Sciences, and 6Mathematics and Statistics, University of Calgary, Calgary, Canada; 7AARP, Washington, DC; and 8Nutritional Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland
1Physical Activity Laboratory, Baker IDI Heart and Diabetes Institute; 2Melbourne School of Population and Global Health, Faculty of Medicine, Dentistry, and Health Sciences, The University of Melbourne, Melbourne, Australia; 3Department of Population Health Research, Alberta Health Services–CancerControl; Departments of 4Oncology, 5Community Health Sciences, and 6Mathematics and Statistics, University of Calgary, Calgary, Canada; 7AARP, Washington, DC; and 8Nutritional Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland
1Physical Activity Laboratory, Baker IDI Heart and Diabetes Institute; 2Melbourne School of Population and Global Health, Faculty of Medicine, Dentistry, and Health Sciences, The University of Melbourne, Melbourne, Australia; 3Department of Population Health Research, Alberta Health Services–CancerControl; Departments of 4Oncology, 5Community Health Sciences, and 6Mathematics and Statistics, University of Calgary, Calgary, Canada; 7AARP, Washington, DC; and 8Nutritional Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karen A. Kopciuk
1Physical Activity Laboratory, Baker IDI Heart and Diabetes Institute; 2Melbourne School of Population and Global Health, Faculty of Medicine, Dentistry, and Health Sciences, The University of Melbourne, Melbourne, Australia; 3Department of Population Health Research, Alberta Health Services–CancerControl; Departments of 4Oncology, 5Community Health Sciences, and 6Mathematics and Statistics, University of Calgary, Calgary, Canada; 7AARP, Washington, DC; and 8Nutritional Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland
1Physical Activity Laboratory, Baker IDI Heart and Diabetes Institute; 2Melbourne School of Population and Global Health, Faculty of Medicine, Dentistry, and Health Sciences, The University of Melbourne, Melbourne, Australia; 3Department of Population Health Research, Alberta Health Services–CancerControl; Departments of 4Oncology, 5Community Health Sciences, and 6Mathematics and Statistics, University of Calgary, Calgary, Canada; 7AARP, Washington, DC; and 8Nutritional Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland
1Physical Activity Laboratory, Baker IDI Heart and Diabetes Institute; 2Melbourne School of Population and Global Health, Faculty of Medicine, Dentistry, and Health Sciences, The University of Melbourne, Melbourne, Australia; 3Department of Population Health Research, Alberta Health Services–CancerControl; Departments of 4Oncology, 5Community Health Sciences, and 6Mathematics and Statistics, University of Calgary, Calgary, Canada; 7AARP, Washington, DC; and 8Nutritional Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Albert R. Hollenbeck
1Physical Activity Laboratory, Baker IDI Heart and Diabetes Institute; 2Melbourne School of Population and Global Health, Faculty of Medicine, Dentistry, and Health Sciences, The University of Melbourne, Melbourne, Australia; 3Department of Population Health Research, Alberta Health Services–CancerControl; Departments of 4Oncology, 5Community Health Sciences, and 6Mathematics and Statistics, University of Calgary, Calgary, Canada; 7AARP, Washington, DC; and 8Nutritional Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Steven C. Moore
1Physical Activity Laboratory, Baker IDI Heart and Diabetes Institute; 2Melbourne School of Population and Global Health, Faculty of Medicine, Dentistry, and Health Sciences, The University of Melbourne, Melbourne, Australia; 3Department of Population Health Research, Alberta Health Services–CancerControl; Departments of 4Oncology, 5Community Health Sciences, and 6Mathematics and Statistics, University of Calgary, Calgary, Canada; 7AARP, Washington, DC; and 8Nutritional Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charles E. Matthews
1Physical Activity Laboratory, Baker IDI Heart and Diabetes Institute; 2Melbourne School of Population and Global Health, Faculty of Medicine, Dentistry, and Health Sciences, The University of Melbourne, Melbourne, Australia; 3Department of Population Health Research, Alberta Health Services–CancerControl; Departments of 4Oncology, 5Community Health Sciences, and 6Mathematics and Statistics, University of Calgary, Calgary, Canada; 7AARP, Washington, DC; and 8Nutritional Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1055-9965.EPI-13-0808 Published May 2014
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Sedentary behavior (sitting time) has been proposed as an independent risk factor for some cancers; however, its role in the development of prostate cancer has not been determined. We examined the prospective associations of self-reported daily sitting time and daily television/video viewing time with the risk of developing or dying from prostate cancer among 170,481 men in the NIH–AARP Diet and Health Study. We estimated HRs and 95% confidence intervals (CI) using Cox proportional hazards regression. Between 1996 and 2006, there were 13,751 incident (including 1,365 advanced) prostate cancer cases identified; prostate cancer mortality (through 2008) was 669. No strong or significant association with prostate cancer risk was seen in fully adjusted models for either daily sitting or television/video time. There were some suggestions of effect modification by body mass index (BMI; interaction for television/video time and BMI, P = 0.02). For total prostate cancer risk, television/video time was associated with a slightly elevated, but nonsignificant, increase amongst obese men (HR = 1.28; 95% CI, 0.98–1.69); a null association was observed amongst overweight men (HR = 1.04; 0.89–1.22); and, for men with a normal BMI, television/video time was associated with a nonsignificant risk decrease (HR = 0.82; 95% CI, 0.66–1.01). Similar patterns were observed for total daily sitting and television/video time in advanced prostate cancer and prostate cancer mortality. Sedentary behavior seems to play a limited role in the development of prostate cancer; however, we cannot rule out potential effect modification by BMI or the impact of measurement error on results. Cancer Epidemiol Biomarkers Prev; 23(5); 882–9. ©2014 AACR.

Introduction

The etiology of prostate cancer remains poorly understood, and few modifiable risk factors have been identified (1). Sedentary behavior (sitting time) is now considered an important chronic disease risk factor, independent of moderate- to vigorous-intensity physical activity (2, 3). Sedentary behavior has been adversely associated with obesity, metabolic dysfunction, and chronic inflammation, processes that may be operative in carcinogenesis (4). Whether sedentary behavior is associated with prostate cancer risk has not yet been established. A small number of studies have examined prostate cancer risk across categories of occupations, comparing sedentary jobs with physically active jobs, but they produced conflicting results. Orsini and colleagues reported that men whose lifetime occupation has involved mostly sitting had a 27% increased risk of prostate cancer (5), whereas Thune and Lund reported a nonsignificant 30% increased risk among men reporting “mostly sedentary” occupations (6). In contrast, Lacey and colleagues found that men whose occupation entailed mainly sitting had a nonsignificant 40% lower risk of prostate cancer than men whose work involved light labor (7). To date, time spent in sedentary behaviors outside of occupation has not been examined in the context of prostate cancer risk. We examined whether self-reported daily sitting or television/video viewing time were associated with prostate cancer, independent of moderate- to vigorous-intensity physical activity.

Materials and Methods

The NIH–AARP Diet and Health Study was established in 1995–1996 with the mailing of a self-administered questionnaire that elicited information on diet, family history of cancer, anthropometry, and other lifestyle factors to 3.5 million members of the AARP. Members selected for the cohort were ages 50 to 71 years and resided in one of the six states (California, Florida, Louisiana, New Jersey, North Carolina, or Pennsylvania) or two metropolitan areas (Atlanta, Georgia and Detroit, or Michigan; ref. 8). Individuals who responded initially (n = 566,401) were sent a second questionnaire within 6 months of receipt of the baseline assessment. The second questionnaire collected more detailed information on cancer risk factors, including physical activity and sedentary behavior. The NIH–AARP Diet and Health Study received ethical approval from the Special Studies Institutional Review Board of the U.S. National Cancer Institute (Bethesda, MD). All participants provided written, informed consent.

Study population

The second questionnaire was completed by 334,906 participants between 1996 and 1997. We excluded participants who had had their baseline (n = 6,959) or second questionnaire (n = 3,424) completed by proxy respondents, females (n = 136,407) and participants with a previous diagnosis of cancer (n = 10,607). We further excluded 1,300 men due to missing data on sedentary behavior variables and 5,728 men with missing or extreme values of body mass index (BMI) or caloric intake. Extreme values were defined as log-transformed values two or more interquartile ranges below the 25th percentile, or two or more interquartile ranges above the 75th percentile. The analytic cohort comprised 170,481 men.

Case ascertainment

Histologically confirmed incident prostate cancer cases, diagnosed through December 31, 2006, were identified through linkage to 11 state cancer registry databases. These state cancer registries met the certification requirements defined by the North American Association of Central Cancer Registries, and were estimated to achieve close to 90% case ascertainment within 24 months (9). Advanced prostate cancer cases had clinical or pathologic tumor classifications of T3 or T4, N1 status, or M1 status, or were incident cases first identified by state cancer registry who subsequently died of prostate cancer between 1995 and 2006. Prostate cancer mortality cases were extracted from the National Death Index through December 31, 2008; mortality cases were not linked to incidence data derived from state cancer registries. Prostate cancer mortality was defined as cases where the underlying or contributing cause of death was prostate cancer.

Assessment of sedentary behavior and covariates

The main exposure variables, total daily sitting and television/video viewing time, were assessed by the second questionnaire. Participants were asked “during a typical 24-hour period over the past 12 months, how many hours did you spend?”: sitting (less than 3 hours; 3–4 hours, 5–6 hours, 7–8 hours, 9 or more hours per day) or watching television or videos (none, less than 1 hour, 1–2 hours, 3–4 hours, 5–6 hours, 7–8 hours, and 9 or more hours per day). We combined the first two response options for television into less than 1 hour per day, due to the very small proportion (0.6%) of respondents who reported watching no television/videos. Similarly, we combined the final two response options for television into 7 or more hours per day (only 1.9% of respondents had reported watching 9 or more hours per day). To ensure an adequate number of cases across categories for analyses examining risk of advanced prostate cancer or prostate cancer mortality, we collapsed the exposure categories for sitting (less than 3 hours, 3–4 hours, 5–6 hours, 7 or more hours per day) and television/video viewing (less than 3 hours, 3–4 hours, 5 or more hours per day).

We examined the bivariate associations of potentially confounding variables with total prostate cancer risk and sedentary behavior variables to help guide the selection of covariates to be included in multivariate models. All covariates were assessed by self-administered questionnaire. Sociodemographic factors were reported at baseline: age (years), race (White, Black, other); marital status (married/de facto, widowed, divorced/separated, never married), and educational attainment (less than 12 years, finished high school, some college, college graduate). Also assessed at baseline were family history of prostate cancer (yes, no), personal history of diabetes (yes, no), BMI (kg/m2), smoking status (never, former, current), caloric intake (kcal, quartiles), and alcohol intake (ethanol g/day, quartiles). Moderate- to vigorous-intensity physical activity in the past 10 years was assessed by the second questionnaire (less than weekly, weekly but less than 1 hour per week, 1–3 hours per week, 4–7 hours per week, more than 7 hours per week). History of prostate-specific antigen testing and digital rectal examination (in past 3 years, yes; no) was also recorded by the second questionnaire.

Statistical analysis

Cox proportional hazards regression was used to estimate multivariate HRs and 95% confidence intervals (CI) of prostate cancer, using the time of follow-up as the underlying time metric. Person-time was calculated starting with the date at second questionnaire return and ending at the date at event (diagnosis of prostate cancer, death, move out of cancer registry catchment area, end of study follow-up). We considered potential interactions of sedentary behavior variables with family history of prostate cancer, race, BMI, moderate- to vigorous-intensity physical activity, history of digital rectal examination, and history of prostate-specific antigen testing. We also examined the risk separately for disease onset before the age of 65 years, and after the age of 65.

Results

The cohort was followed for an average period of 8.5 years, during which 13,751 incident prostate cancer cases were ascertained. The median age at diagnosis was 69.5 years. We also examined associations of sedentary behavior with risk of advanced prostate cancer (n = 1,365) and with prostate cancer mortality (n = 669).

The characteristics of the study population at baseline are presented in Table 1. Greater amounts of sitting time were associated with receiving a college education, a higher BMI, personal history of diabetes, more television viewing, and less recreational physical activity.

View this table:
  • View inline
  • View popup
Table 1.

Baseline characteristics of the NIH–AARP study population (n = 170,481) by daily sitting time categories, 1995–1996

Neither self-reported daily sitting time nor television/video viewing time was associated with risk of total or advanced prostate cancer, nor with prostate cancer mortality (Tables 2 and 3). There were no meaningful differences in HRs or 95% CIs between age-adjusted and multivariate models; hence only multivariate results are presented.

View this table:
  • View inline
  • View popup
Table 2.

Risk of prostate cancer according to categories of daily sitting among 170,481 men in the NIH–AARP Diet and Health Study, 1996–2006

View this table:
  • View inline
  • View popup
Table 3.

Risk of prostate cancer according to categories of television or video viewing among 170,481 men in the NIH–AARP Diet and Health Study, 1996–2006

There were no interaction effects between sitting time or television/video viewing time and family history of disease, race, moderate- to vigorous-intensity physical activity, history of digital rectal examination, or history of prostate-specific antigen testing (results not shown). However, a statistically significant interaction effect was found for television/video viewing time and BMI (P = 0.02). We therefore stratified our analyses by BMI, and saw some suggestion that sedentary behavior may be associated with an increased risk of prostate cancer amongst obese men, and with a reduced risk of prostate cancer amongst men in the healthy weight range (Tables 2 and 3).

For men ages less than 65 years, no significant association was seen for daily sitting time (HR ≥7 vs. <3 h/day = 0.92; 95% CI, 0.74–1.15) or for television/video viewing time (HR ≥5 vs. <3 h/day = 1.01; 95% CI, 0.81–1.26). Similarly, amongst men ages 65 years or older, there was no association for either daily sitting time (HR = 0.92; 95% CI, 0.75–1.12) or for television/video viewing time (HR = 0.90; 95% CI, 0.75–1.09).

Discussion

In this large, prospective investigation, we found scant evidence for associations between self-reported measures of sedentary behavior and risk of prostate cancer. The data were suggestive of some effect modification by BMI category for television/video viewing time and total prostate cancer risk, and for both daily sitting and television/video viewing time and advanced prostate cancer risk/prostate cancer mortality.

Previous studies that examined prostate cancer risk across occupational activity categories found conflicting results (5–7). These studies used an estimate of usual occupational activity to examine the association with sitting in the workplace, whereas we were able to examine prostate cancer risk in relation to estimated daily sitting and television/video viewing time (a highly prevalent leisure-time sedentary behavior). It is unlikely, however, that the different behavior setting in which sitting occurs would significantly affect the biologic response to the exposure. Hence, our mostly null results provide further conflicting evidence pertaining to sedentary behavior and prostate cancer risk.

The etiology of prostate cancer remains poorly understood, and few modifiable risk factors have been identified, although there is evidence to suggest that the interrelations of energy intake, body composition, and physical activity play some role in prostate cancer etiology (10). Studies that have examined the associations between physical activity and prostate cancer risk stratified by BMI have demonstrated no associations amongst healthy weight and overweight men, but an inverse association amongst obese men (1).

The reasons for the observed risk variation across BMI categories in this study are not clear. The apparent elevation in risk amongst obese men could reflect the compounded biologic exposures resulting from obesity and sedentary behavior. For example, both obesity and sedentary behavior have been independently associated with metabolic dysfunction (4), a factor that may facilitate prostate cancer development and progression (1, 11). The favorable muscle:fat ratio of lean men may help to counteract some of the deleterious biologic consequences of sedentary behavior that may be operative in prostate cancer risk (12). Obesity has been hypothesized to mediate many of the pathways by which sedentary behavior affects cancer risk (4). The associations between sedentary behavior, body composition, and prostate cancer are clearly complex, and further research is necessary to elucidate these pathways.

A previous report from the NIH–AARP Diet and Health Study did not find a significant association between vigorous-intensity physical activity and total, advanced, or fatal prostate cancer (13). However, another report from the same cohort examined the associations of physical activity with prostate cancer risk separately for White and Black men, and found that 4 or more hours of moderate/vigorous intensity physical activity, compared to with infrequent activity, during early adulthood provided a 35% lower risk of prostate cancer (14). No significant interaction effect was noted in our study; hence, we did not stratify our analyses by race.

In this study, advanced prostate cancer was defined primarily by tumor—node—metastasis criteria. The Gleason scoring system offers a prostate cancer-specific method for defining advanced disease, and this method would likely have enlarged the number of cases defined as “advanced.” For the purpose of our analyses, however, it is unlikely that the use of the Gleason scoring system would have altered the study results, given the consistently null associations demonstrated across the different prostate cancer outcomes.

Our findings imply that sedentary behavior does not make a significant, independent contribution toward prostate cancer risk. However, some pertinent methodologic issues should be considered when interpreting the results. It is possible that use of self-report measures led to measurement error, biasing results toward the null. Although the psychometric properties of the sedentary behavior items used in this study have not been established, they have previously been associated with an increased risk of all-cause and cancer mortality (15), colon cancer (16), and endometrial cancer (17), and are similar to items that have demonstrated reasonable reliability and validity (18–21). However, the validation of these similar items was limited by the lack of adequate gold-standard for sedentary behavior. Studies have estimated convergent validity by comparing sedentary behavior items against activity logs (19, 20) or accelerometer data (19, 21), which can be imprecise.

Screening bias has also been suggested as a possible problem in studies such as ours. Health-conscious men may spend less time sitting and also may be more likely to be screened for, and therefore diagnosed with, prostate cancer (22). We adjusted our multivariate models for participants' prostate-specific antigen and digital rectal examination screening before baseline, but were unable to adjust for subsequent screening, and therefore our adjustment may be incomplete. Study strengths include the prospective design, large sample, and ability to control for many important confounding factors. We were also able to isolate advanced cases of prostate cancer to examine these separately.

This is the first study to consider whether self-reported daily sitting or television/video viewing time was associated with prostate cancer risk. We did not demonstrate an association, but there is sufficient biologic plausibility to warrant further investigation that may confirm or refute our findings. Future studies would benefit from the use of more accurate and comprehensive assessment of sedentary behavior, such as previous day recalls or objective measures of sedentary time (23, 24).

Disclosure of Potential Conflicts of Interest

A.R. Hollenbeck is a consultant/advisory board member of Society of Psychologists in Management and Love/Avon Army of Women Scientific Advisory Council. No potential conflicts of interest were disclosed by the other authors.

Disclaimer

The views expressed herein are solely those of the authors and do not necessarily reflect those of the FCDC or FDOH. The Pennsylvania Department of Health specifically disclaims responsibility for any analyses, interpretations, or conclusions.

Authors' Contributions

Conception and design: B.M. Lynch, C.M. Friedenreich, A.R. Hollenbeck, C.E. Matthews

Development of methodology: C.M. Friedenreich, S.C. Moore

Acquisition of data (provided animals, acquired and managed patients, provided facilities, etc.): A.R. Hollenbeck

Analysis and interpretation of data (e.g., statistical analysis, biostatistics, computational analysis): B.M. Lynch, C.M. Friedenreich, K.A. Kopciuk, S.C. Moore

Writing, review, and/or revision of the manuscript: B.M. Lynch, C.M. Friedenreich, K.A. Kopciuk, A.R. Hollenbeck, S.C. Moore, C.E. Matthews

Administrative, technical, or material support (i.e., reporting or organizing data, constructing databases): C.E. Matthews

Study supervision: C.M. Friedenreich, C.E. Matthews

Grant Support

This work was supported by the AARP and the Intramural Research Program of the NIH, National Cancer Institute. Brigid M. Lynch is funded by a Public Health Training Fellowship from the National Health and Medical Research Council (586727) and the Victorian Government's Operational Infrastructure Support Program. Christine M. Friedenreich is funded by an Alberta Innovates-Health Solutions Health Senior Scholar Award, and is the Alberta Cancer Foundation Weekend to End Women's Cancers Breast Cancer Chair.

Acknowledgments

The authors thank participants in the NIH–AARP Diet and Health Study for their outstanding cooperation, Sigurd Hermansen and Kerry Grace Morrissey from Westat for study outcomes ascertainment and management, Leslie Carroll at Information Management Services for data support and analysis, and Farah Khandwala (Alberta Health Services—CancerControl) for her assistance with data management. Cancer incidence data from the Atlanta metropolitan area were collected by the Georgia Center for Cancer Statistics, Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia. Cancer incidence data from California were collected by the California Cancer Registry, California Department of Public Health's Cancer Surveillance and Research Branch, Sacramento, California. Cancer incidence data from the Detroit metropolitan area were collected by the Michigan Cancer Surveillance Program, Community Health Administration, Lansing, Michigan. The Florida cancer incidence data used in this report were collected by the Florida Cancer Data System (Miami, Florida) under contract with the Florida Department of Health, Tallahassee, Florida. Cancer incidence data from Louisiana were collected by the Louisiana Tumor Registry, Louisiana State University Health Sciences Center School of Public Health, New Orleans, Louisiana. Cancer incidence data from New Jersey were collected by the New Jersey State Cancer Registry, Cancer Epidemiology Services, New Jersey State Department of Health, Trenton, New Jersey. Cancer incidence data from North Carolina were collected by the North Carolina Central Cancer Registry, Raleigh, North Carolina. Cancer incidence data from Pennsylvania were supplied by the Division of Health Statistics and Research, Pennsylvania Department of Health, Harrisburg, Pennsylvania. Cancer incidence data from Arizona were collected by the Arizona Cancer Registry, Division of Public Health Services, Arizona Department of Health Services, Phoenix, Arizona. Cancer incidence data from Texas were collected by the Texas Cancer Registry, Cancer Epidemiology and Surveillance Branch, Texas Department of State Health Services, Austin, Texas. Cancer incidence data from Nevada were collected by the Nevada Central Cancer Registry, State Health Division, State of Nevada Department of Health and Human Services, Las Vegas, Nevada.

  • Received August 7, 2013.
  • Revision received December 11, 2013.
  • Accepted January 4, 2014.
  • ©2014 American Association for Cancer Research.

References

  1. 1.↵
    1. Coumeya KS,
    2. Friedenreich CM
    1. Leitzmann MF
    . Physical activity and genitourinary cancer prevention. In: Coumeya KS, Friedenreich CM , editors. Physical activity and cancer. Heidelberg: Springer-Verlag; 2011.
  2. 2.↵
    1. Dunstan DW,
    2. Howard BV,
    3. Healy GN,
    4. Owen N
    . Too much sitting: a health hazard. Diabetes Res Clin Pract 2012;97:368–76.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Owen N,
    2. Bauman A,
    3. Brown W
    . Too much sitting: a novel and important predictor of chronic disease risk? Br J Sports Med 2009;43:81–3.
    OpenUrlFREE Full Text
  4. 4.↵
    1. Lynch BM
    . Sedentary behavior and cancer: a systematic review of the literature and proposed biological mechanisms. Cancer Epidemiol Biomarkers Prev 2010;19:2691–709.
    OpenUrlAbstract/FREE Full Text
  5. 5.↵
    1. Orsini N,
    2. Bellocco R,
    3. Bottai M,
    4. Pagano M,
    5. Andersson SO,
    6. Johansson JE,
    7. et al.
    A prospective study of lifetime physical activity and prostate cancer incidence and mortality. Br J Cancer 2009;101:1932–8.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Thune I,
    2. Lund E
    . Physical activity and the risk of prostate and testicular cancer: a cohort study of 53,000 Norwegian men. Cancer Causes Control 1994;5:549–56.
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Lacey J,
    2. Deng J,
    3. Dosemeci M,
    4. Gao YT,
    5. Mostofi FK,
    6. Sesterhenn IA,
    7. et al.
    Prostate cancer, benign prostatic hyperplasia and physical activity in Shanghai, China. Int J Epidemiol 2001;30:341–9.
    OpenUrlAbstract/FREE Full Text
  8. 8.↵
    1. Schatzkin A,
    2. Subar AF,
    3. Thompson FE,
    4. Harlan LC,
    5. Tangrea J,
    6. Hollenbeck AR,
    7. et al.
    Design and serendipity in establishing a large cohort with wide dietary intake distributions: the National Institutes of Health–American Association of Retired Persons Diet and Health Study. Am J Epidemiol 2001;154:1119–25.
    OpenUrlAbstract/FREE Full Text
  9. 9.↵
    1. Michaud DS,
    2. Midthune D,
    3. Hermansen S,
    4. Leitzmann MF,
    5. Harlan LC,
    6. Kipnis V,
    7. et al.
    Comparison of cancer registry case ascertainment with SEER estimates and self-reporting in a subset of the NIH–AARP Diet and Health Study. J Registry Manag 2005;32:70–5.
    OpenUrl
  10. 10.↵
    1. Cao Y,
    2. Ma J
    . Body mass index, prostate cancer-specific mortality, and biochemical recurrence: a systematic review and meta-analysis. Cancer Prev Res 2011;4:486–501.
    OpenUrlAbstract/FREE Full Text
  11. 11.↵
    1. Wilson KM,
    2. Giovannucci EL,
    3. Mucci LA
    . Lifestyle and dietary factors in the prevention of lethal prostate cancer. Asian J Androl 2012;14:365–74.
    OpenUrlPubMed
  12. 12.↵
    1. Srikanthan P,
    2. Karlamangla AS
    . Relative muscle mass is inversely associated with insulin resistance and prediabetes. Findings from the third National Health and Nutrition Examination Survey. J Clin Endocrinol Metab 2011;96:2898–903.
    OpenUrlCrossRefPubMed
  13. 13.↵
    1. Moore SC,
    2. Peters TM,
    3. Ahn J,
    4. Park Y,
    5. Schatzkin A,
    6. Albanes D,
    7. et al.
    Physical activity in relation to total, advanced, and fatal prostate cancer. Cancer Epidemiol Biomarkers Prev 2008;17:2458–66.
    OpenUrlAbstract/FREE Full Text
  14. 14.↵
    1. Moore SC,
    2. Peters TM,
    3. Ahn J,
    4. Park Y,
    5. Schatzkin A,
    6. Albanes D,
    7. et al.
    Age-specific physical activity and prostate cancer risk among white men and black men. Cancer 2009;115:5060–70.
    OpenUrlCrossRefPubMed
  15. 15.↵
    1. Matthews CE,
    2. George SM,
    3. Moore SC,
    4. Bowles HR,
    5. Blair A,
    6. Park Y,
    7. et al.
    Amount of time spent in sedentary behaviors and cause-specific mortality in US adults. Am J Clin Nutr 2012;95:437–45.
    OpenUrlAbstract/FREE Full Text
  16. 16.↵
    1. Howard RA,
    2. Freedman DM,
    3. Park Y,
    4. Hollenbeck A,
    5. Schatzkin A,
    6. Leitzmann MF
    . Physical activity, sedentary behavior, and the risk of colon and rectal cancer in the NIH–AARP Diet and Health Study. Cancer Causes Control 2008;19:939–53.
    OpenUrlCrossRefPubMed
  17. 17.↵
    1. Moore SC,
    2. Gierach GL,
    3. Schatzkin A,
    4. Matthews CE
    . Physical activity, sedentary behaviours, and the prevention of endometrial cancer. Br J Cancer 2010;103:933–8.
    OpenUrlCrossRefPubMed
  18. 18.↵
    1. Dipietro L,
    2. Caspersen CJ,
    3. Ostfeld AM,
    4. Nadel ER
    . A survey for assessing physical activity among older adults. Med Sci Sports Exerc 1993;25:628–42.
    OpenUrlPubMed
  19. 19.↵
    1. Matton L,
    2. Wijndaele K,
    3. Duvigneaud N,
    4. Duquet W,
    5. Philippaerts R,
    6. Thomis M,
    7. et al.
    Reliability and validity of the Flemish physical activity computerized questionnaire in adlults. Res Q Exerc Sport 2007;78:293–306.
    OpenUrlCrossRefPubMed
  20. 20.↵
    1. Salmon J,
    2. Owen N,
    3. Crawford D,
    4. Bauman A,
    5. Sallis JF
    . Physical activity and sedentary behavior: population-based study of barriers, enjoyment, and preference. Health Psychol 2003;22:178–88.
    OpenUrlCrossRefPubMed
  21. 21.↵
    1. Rosenberg DE,
    2. Norman GJ,
    3. Wagner N,
    4. Patrick K,
    5. Calgas KF,
    6. Sallis JF
    . Reliability and validity of the Sedentary Behavior Questionnaires (SBQ) for Adults. J Phys Act Health 2010;7:697–705.
    OpenUrlPubMed
  22. 22.↵
    1. Friedenreich CM,
    2. Neilson HK,
    3. Lynch BM
    . State of the epidemiologic evidence on physical activity and cancer prevention. Eur J Cancer 2010;46:2593–604.
    OpenUrlCrossRefPubMed
  23. 23.↵
    1. Matthews C,
    2. Moore S,
    3. George S,
    4. Sampson J,
    5. Bowles H
    . Improving self-reports of active and sedentary behaviors in large epidemiologic studies. Exerc Sport Sci Rev 2012 40:118–26.
    OpenUrlPubMed
  24. 24.↵
    1. Matthews CE,
    2. Keadle SK,
    3. Sampson J,
    4. Lyden K,
    5. Bowles HR,
    6. Moore SC,
    7. et al.
    Validation of a previous-day recall measure of active and sedentary behaviors. Med Sci Sports Exerc 2013;45:1629–38.
    OpenUrl
PreviousNext
Back to top
Cancer Epidemiology Biomarkers & Prevention: 23 (5)
May 2014
Volume 23, Issue 5
  • Table of Contents
  • Table of Contents (PDF)

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Epidemiology, Biomarkers & Prevention article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Sedentary Behavior and Prostate Cancer Risk in the NIH–AARP Diet and Health Study
(Your Name) has forwarded a page to you from Cancer Epidemiology, Biomarkers & Prevention
(Your Name) thought you would be interested in this article in Cancer Epidemiology, Biomarkers & Prevention.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Sedentary Behavior and Prostate Cancer Risk in the NIH–AARP Diet and Health Study
Brigid M. Lynch, Christine M. Friedenreich, Karen A. Kopciuk, Albert R. Hollenbeck, Steven C. Moore and Charles E. Matthews
Cancer Epidemiol Biomarkers Prev May 1 2014 (23) (5) 882-889; DOI: 10.1158/1055-9965.EPI-13-0808

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Sedentary Behavior and Prostate Cancer Risk in the NIH–AARP Diet and Health Study
Brigid M. Lynch, Christine M. Friedenreich, Karen A. Kopciuk, Albert R. Hollenbeck, Steven C. Moore and Charles E. Matthews
Cancer Epidemiol Biomarkers Prev May 1 2014 (23) (5) 882-889; DOI: 10.1158/1055-9965.EPI-13-0808
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Disclosure of Potential Conflicts of Interest
    • Disclaimer
    • Authors' Contributions
    • Grant Support
    • Acknowledgments
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Common Variants in High-Risk Pancreatic Cancer Patients
  • Colorectal Cancer Screening Among Asian Americans
  • Quality of Online Cancer-Related Clinical Trial Information
Show more Short Communication
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • Online First
  • Current Issue
  • Past Issues

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Epidemiology, Biomarkers & Prevention

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Epidemiology, Biomarkers & Prevention
eISSN: 1538-7755
ISSN: 1055-9965

Advertisement